Wednesday Parallel Session 26 October - Innovative Ideas and Options for FMD Management.

Session I: Global Progress Against FMD: Session Organised by the FMD Working Group of FAO and OIE

• Global, Regional and National Progress of FMD Control S. Metwally 
• FMD Disease Risk Assessment and Progress on Risk-Based Control Program. A. Bulut 
• National Activities for FMD Control in Afghanistan G. Ferrari

Session II: Vaccine Efficacy (GFRA)

• Advances and Gaps in Vaccine Modelling R. Reeve
• Selection of FMD Vaccines in Vietnam D. Do Huu
• The Value of In Vitro Antigen Matching in Predicting Vaccine Protection W. Vosloo
• Correlation of Serological Response After Vaccination Against FMDV and Protection Against Challenge in Pigs P. L. Éble
• Novel Marker FMD Virus Vaccine Molecularly Bound to Nanolipoprotein Adjuvant E. Rieder
• Antigenic Refocusing of A SAT2 FMD Virus Through Epitope Dampening T. Ramulongo
• Estimate of Cross-Protection Provided by an FMDV O-BFS Vaccine in the Tunisian Epidemiological Context E. Brocchi

Session III: FMD Endemicity (GFRA)

• The Role of Asymptomatic Carriers in FMD Ecology; Unifying Knowledge from Controlled Laboratory Experiments and Filed Studies J. Arzt
• Next Generation Sequencing Reveals New Southern African Territories Genotypes Bringing Us Closer to Understanding the History of FMD Virus in Africa N. Knowles
• Waves of FMD in East Africa and Advances in Practical Surveillance T. Lembo 
• Genetic and Antigenic Variation of FMD Virus During Persistence in Naturally Infected Cattle and Buffalo J. K. Biswal
• Molecular Epidemiology of Foot-and-Mouth Disease Viruses in Southern Africa C. Kasanga
• A Novel Approach for Endemic FMD in Sub-Saharan Africa M. Bronsvoort

Thursday Parallel Session 27 October

Session IV: New Vaccines

• A Prime-Boost Vaccination Strategy in Cattle to Prevent Serotype O FMDV Infection Using A "Single-Cycle" Alphavirus Vector and Empty Capsid Particles G. J. Belsham
• Vaccine Efficacy of FMD Virus-Like Particles Produced by the Baculovirus Expression System E. van den Born
• Enhanced Potency and Immunogenicity for Cattle Vaccinated with FMD A Serotype Vaccine Adjuvanted with Poly (I:C) S. Parida
• Effect of the Antigen Payload, Polyvalency and Re-Vaccination in the Protection Conferred by FMD Vaccines Against Heterologous Challenge in Cattle  M. Pérez-Filgueira
• Immune Responses to Foot-and-Mouth Disease Virus in Guinea Pigs After Vaccination with Canine Adenovirus Vector S. Lacour
• EU Authorisation of Novel Vaccines M. Ilott

Session V: Improving Current Vaccines

• Application of Indirect and Avidity ELISA Tests to Assess Anti-FMDV Antibodies Induced by Vaccination in Buffalo and Swine Serum Samples A. Capozzo
• Demonstration of Early Protection Against FMD Virus Seven Days Post-Vaccination L. Mouton
• Efficacy of a FMD Inactivated Vaccine (Aftovaxpur DOE), Administered at a 1ml Dose to Sheep C. Hamers
• No Heterologous Protection with FMD SAT2 SAU Vaccine Against SAT2 BOT Challenge A. Dekker
• Selection of an Adjuvant to Raise Polyclonal Antibodies to FMDV in Rabbits and Guinea-Pigs B. Sanz-Bernardo
• Application of A Mouse Model for Effective Evaluation of FMD Vaccine J.H. Park 
• Development of a Virulent FMD Challenge Model in Sheep L. Mouton

Session VI: Preventing FMD: Tools to Assist Decision Making

• FMD in Turkey- Livestock Movements and Mathematical Modelling P. Dawson

• The U.S. Animal Movement Model (USAMM), A Bayesian Approach to Modeling of a Partially Observed Continental Scale Livestock Movement Network P. Brommesson
• Real-Time Bayesian Data Assimilation and Prediction for Livestock Epidemics C. Jewell
• Real-Time Updating in Emergency Response to FMD Outbreaks W. Probert
• Haebos, A Hybrid Agent-and Equation-Based Model of FMD in Vermont A. Yoak
• Reducing Computing Times of Spatially Explicit FMD Models S. Sellman

Session VII: Innovation in Diagnosis

• Development of Novel Virus Neutralization Assay Using QRT-PCR-Based Endpoint Assessment for Rapid Detection and Titration of Neutralising Antibodies Against FMD Virus Z. Zhang
• Competitive Luminex Immunoassays for the Detection of Antibodies to FMD and Vesicular Stomatitis Viruses in Multiple Susceptible Hosts C. K. Nfon
• Tailed Primers Enhance Real-Time RT-PCR Detection of FMD Virus D. Lefebvre
• Development of One-Step Multiplex RT-PCR Assay for Differentiation of FMDV Serotypes A, O and SAT2 Circulating in Egypt A.A. Shehata
• Go Prime: In Silico Testing of rRT-PCR Primers and Probes for Diagnosis of FMD E. Howson
• Development of a Reference FMD Virus Antigen Panel for the Consistent Validation of Diagnostic Assays A. Morris
• Establishment and Validation of Two Duplex One-Step Real-Time RT-PCR Assays for Diagnosis of FMD L. Bakkali-Kassimi
• Evaluation of Alternative Cell Lines for the Isolation of FMDV A. Gray
• Comparison of Two Commercial NSP Antibody Tests (PRIOCHECK® AND IDVET® FMDV NS ELISAS) to Detect Infection in Vaccinated Animals (DIVA) S. Parida
• Detection of FMD Virus Carrier Cattle: Development and Evaluation of an IGA ELISA Kit for O, A and Asia 1 Serotypes K. Parekh
• The Challenges of Using in-Vitro Tests for Vaccine Matching A. Bin-Tarif

Friday Parallel Session 2 28 October - Innovative Surveillance and Diagnostics

G4: Innovative Surveillance Options for Field Use

• Evaluation of Oral Swabs for FMDV Surveillance P. Kirkland
• Use of Lateral Flow Device For Safe and Low Cost Shipment of FMDV Suspected Samples S. Blaise-Boisseau
• Development of a Successful Surveillance Model for FMD in Pakistan M. Hussain

G5: Diagnostics: Harmonisation of Laboratory Tests, and Tools to Share Sequence

• Results of the 2015 Proficiency Testing Scheme A. Ludi 
• Vibasys and FMDV-Tools: Practical Resources for FMD Virus Sequence Analysis P. Ribeca 
• Antigen-Detection ELISA Performance VS Virus Evolution V. Mioulet
• Do Commercially Available Lysis Buffers Inactivate FMD Virus? B. Wood

G6: Biocontainment of FMDV: Challenges and Solutions for Laboratory Biorisk Management

• A Contaminated Environment is an Efficient Route of Transmission for FMD Virus  C. Colenutt
• Evaluating the Survival of FMD Virus in The Environment E. Brown
• The New Zealand National Biocontainment Laboratory Project - Innovative Approaches to meet Testing Requirements in the Event of an FMD Outbreak R. P.Spence
• EU FMDV Biorisk Management Committee K. Summermatter

G10: New Developments in Wildlife (FMDV in African Buffalo)

• Serological and Molecular Surveillance of FMDV Transmission Events Over Time in an Isolated African Buffalo Herd in the Kruger National Park K. Scott
• FMD in African Buffalo (Syncerus Caffer): Differences in Host Responses Between SAT1, 2 and 3 in Experimental and Natural Infection B. Beechler
• Specificity of FMD Surveillance in Wild Boars Y. Ivanov
• Wildlife Surveillance and Control for Foot-and-Mouth Disease T. Alexandrov

G11: Pathology and Pathological Basis of Persistence

• Pathological Change of the Development of the Vesicular Lesion in Pigs Experimentally Infected With the FMD Virus O/JPN/2010 M. Yamada
• FMDV-Host Interaction in a Model of Persistenly Infected Bovine Cells S. Blaise-Boisseau
• Localization of FMD RNA and Viral Antigens in Different Tissues From Apparently Healthy Cattle and Buffalo Under Natural Condition in India: Pathology and Pathological Basis of Persistence R. Ranjan

G12: Funding Innovation: Q&A 

•  Funding and Innovation Q&A